Trial Profile
Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy (SMART) in Asthma Patients Across Asia: SMARTASIA.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2020
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms SMARTASIA
- Sponsors AstraZeneca
- 13 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 May 2010 Planned end date changed from 1 Apr 2010 to 1 Aug 2010 as reported by ClinicalTrials.gov.
- 19 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.